ACC 2025 - 5 Highlights (Day 1 and Day 2) - International Episode
Falha ao colocar no Carrinho.
Falha ao adicionar à Lista de Desejos.
Falha ao remover da Lista de Desejos
Falha ao adicionar à Biblioteca
Falha ao seguir podcast
Falha ao parar de seguir podcast
ACC 2025 - 5 Highlights (Day 1 and Day 2) - International Episode
-
Narrado por:
-
De:
Sobre este áudio
Send us a text
Hey, Clube da Cardio community! This is a special episode — our very first international edition.
In this episode, you will find the top 5 featured studies from the first two days of the American College of Cardiology Congress (ACC 2025):
1. Evolut Low Risk — 5-year follow-up
2. PRAGUE-25 — Lifestyle plus antiarrhythmic drugs versus ablation in obese patients with atrial fibrillation
3. FAME-3 — Fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting in multivessel coronary artery disease
4. SOUL — Semaglutide effects on cardiovascular outcomes in patients with type 2 diabetes
5. SMART-CHOICE — Clopidogrel versus aspirin as monotherapy after percutaneous coronary intervention
Article analysis by Dr. Pâmela Valelongo — Cardiologist at Hospital Israelita Albert Einstein and Co-founder of Clube da Cardio.
Voice by Andrea — Artificial Intelligent Assistant of Clube da Cardio.
Enjoy the episode and share it with your colleagues!
Follow us on Instagram: @clubedacardio
Don’t forget to subscribe and share this episode with colleagues who may find it helpful. See you in the next one.
🫀Curso PÓS-OP 3.0 inscrições abertas por 48h 👇🏻
📚https://clubedacardio.com.br/pagina-de-inscricao2/